Cargando…

Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors

Hepatic fibrogenesis involves the activation of hepatic stellate cells (HSCs), which synthesize excess extracellular matrix and contribute to the development of liver fibrosis. In a prior study we tested the effect of combined treatment with taurine, epigallocatechin gallate and genistein on the dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Luo, Ying, Zhang, Xuerong, Lin, Xing, He, Min, Liao, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821629/
https://www.ncbi.nlm.nih.gov/pubmed/24129183
http://dx.doi.org/10.3390/ijms141020543
_version_ 1782290331565293568
author Li, Yan
Luo, Ying
Zhang, Xuerong
Lin, Xing
He, Min
Liao, Ming
author_facet Li, Yan
Luo, Ying
Zhang, Xuerong
Lin, Xing
He, Min
Liao, Ming
author_sort Li, Yan
collection PubMed
description Hepatic fibrogenesis involves the activation of hepatic stellate cells (HSCs), which synthesize excess extracellular matrix and contribute to the development of liver fibrosis. In a prior study we tested the effect of combined treatment with taurine, epigallocatechin gallate and genistein on the development of alcohol-induced liver fibrosis in vitro. In this study, the biological activity of the combination of these molecules was assessed by measuring its effect on cell proliferation, fibrosis-related gene expression, and proteomic expression profiling in the activated HSC cell line, HSC-T6. HSC-T6 cells were incubated with different concentrations of the drug combination taurine, epigallocatechin gallate and genistein. Cell proliferation was evaluated by MTT assay. Transforming growth factor β1 (TGF-β1), collagen type I (Col-I), matrix metalloproteinase-2 (MMP-2), and tissue inhibitor of metalloproteinases 1 and 2 (TIMP-1 and TIMP-2) mRNA were analyzed by semi-quantitative reverse-transcription PCR. Proteomic profiling of HSC-T6 cells was also performed by SELDI-TOF-MS. Combined drug treatment significantly inhibited cell proliferation and TGF-β1, Col-I, TIMP-1 and TIMP-2 mRNA expression in activated HSC-T6 cells, while the expression of MMP-2 mRNA increased. A total of 176 protein m/z peaks were identified. The intensities of 10 protein peaks were downregulated and two protein peaks were upregulated in HSC-T6 cells after combined drug treatment. In conclusion, combined drug treatment with taurine, epigallocatechin gallate and genistein can inhibit HSC proliferation, and impact fibrosis-related gene and protein expression. The antifibrotic effects of this drug combination may be due to its effects on the expression of fibrogenic genes.
format Online
Article
Text
id pubmed-3821629
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-38216292013-11-11 Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors Li, Yan Luo, Ying Zhang, Xuerong Lin, Xing He, Min Liao, Ming Int J Mol Sci Article Hepatic fibrogenesis involves the activation of hepatic stellate cells (HSCs), which synthesize excess extracellular matrix and contribute to the development of liver fibrosis. In a prior study we tested the effect of combined treatment with taurine, epigallocatechin gallate and genistein on the development of alcohol-induced liver fibrosis in vitro. In this study, the biological activity of the combination of these molecules was assessed by measuring its effect on cell proliferation, fibrosis-related gene expression, and proteomic expression profiling in the activated HSC cell line, HSC-T6. HSC-T6 cells were incubated with different concentrations of the drug combination taurine, epigallocatechin gallate and genistein. Cell proliferation was evaluated by MTT assay. Transforming growth factor β1 (TGF-β1), collagen type I (Col-I), matrix metalloproteinase-2 (MMP-2), and tissue inhibitor of metalloproteinases 1 and 2 (TIMP-1 and TIMP-2) mRNA were analyzed by semi-quantitative reverse-transcription PCR. Proteomic profiling of HSC-T6 cells was also performed by SELDI-TOF-MS. Combined drug treatment significantly inhibited cell proliferation and TGF-β1, Col-I, TIMP-1 and TIMP-2 mRNA expression in activated HSC-T6 cells, while the expression of MMP-2 mRNA increased. A total of 176 protein m/z peaks were identified. The intensities of 10 protein peaks were downregulated and two protein peaks were upregulated in HSC-T6 cells after combined drug treatment. In conclusion, combined drug treatment with taurine, epigallocatechin gallate and genistein can inhibit HSC proliferation, and impact fibrosis-related gene and protein expression. The antifibrotic effects of this drug combination may be due to its effects on the expression of fibrogenic genes. Molecular Diversity Preservation International (MDPI) 2013-10-14 /pmc/articles/PMC3821629/ /pubmed/24129183 http://dx.doi.org/10.3390/ijms141020543 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Li, Yan
Luo, Ying
Zhang, Xuerong
Lin, Xing
He, Min
Liao, Ming
Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors
title Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors
title_full Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors
title_fullStr Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors
title_full_unstemmed Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors
title_short Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors
title_sort combined taurine, epigallocatechin gallate and genistein therapy reduces hsc-t6 cell proliferation and modulates the expression of fibrogenic factors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821629/
https://www.ncbi.nlm.nih.gov/pubmed/24129183
http://dx.doi.org/10.3390/ijms141020543
work_keys_str_mv AT liyan combinedtaurineepigallocatechingallateandgenisteintherapyreduceshsct6cellproliferationandmodulatestheexpressionoffibrogenicfactors
AT luoying combinedtaurineepigallocatechingallateandgenisteintherapyreduceshsct6cellproliferationandmodulatestheexpressionoffibrogenicfactors
AT zhangxuerong combinedtaurineepigallocatechingallateandgenisteintherapyreduceshsct6cellproliferationandmodulatestheexpressionoffibrogenicfactors
AT linxing combinedtaurineepigallocatechingallateandgenisteintherapyreduceshsct6cellproliferationandmodulatestheexpressionoffibrogenicfactors
AT hemin combinedtaurineepigallocatechingallateandgenisteintherapyreduceshsct6cellproliferationandmodulatestheexpressionoffibrogenicfactors
AT liaoming combinedtaurineepigallocatechingallateandgenisteintherapyreduceshsct6cellproliferationandmodulatestheexpressionoffibrogenicfactors